Novavax, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2023
Total Assets: $1.80B
Liabilities Breakdown FY2023
Total Liabilities: $2.51B
Asset Breakdown
Total Assets: $1.80B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $568.5M | 31.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $41.7M | 2.3% |
| Property, Plant & Equipment | $305.8M | 17.0% |
| Goodwill | $127.5M | 7.1% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $754.1M | 42.0% |
Liabilities Breakdown
Total Liabilities: $2.51B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $132.6M | 5.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $2.38B | 94.7% |